Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
NVCR NovoCure Limited daily Stock Chart
NVCR [NASD]
NovoCure Limited
Healthcare | Medical Appliances & Equipment | USA
statements
Index- P/E- EPS (ttm)-0.08 Insider Own10.30% Shs Outstand103.95M Perf Week9.88%
Market Cap6.81B Forward P/E98.64 EPS next Y0.66 Insider Trans-8.14% Shs Float83.41M Perf Month-15.24%
Income-7.20M PEG- EPS next Q0.03 Inst Own76.70% Short Float4.81% Perf Quarter-25.19%
Sales351.30M P/S19.38 EPS this Y89.30% Inst Trans10.95% Short Ratio3.86 Perf Half Y-12.88%
Book/sh2.19 P/B29.91 EPS next Y159.38% ROA-1.70% Target Price88.86 Perf Year38.89%
Cash/sh3.14 P/C20.88 EPS next 5Y- ROE-4.20% 52W Range41.51 - 98.84 Perf YTD-22.27%
Dividend- P/FCF422.90 EPS past 5Y40.20% ROI0.20% 52W High-33.73% Beta2.01
Dividend %- Quick Ratio4.80 Sales past 5Y86.70% Gross Margin74.80% 52W Low57.79% ATR6.73
Employees782 Current Ratio5.10 Sales Q/Q42.30% Oper. Margin-0.30% RSI (14)45.44 Volatility8.51% 10.81%
OptionableYes Debt/Eq0.69 EPS Q/Q125.50% Profit Margin-2.10% Rel Volume0.64 Prev Close68.33
ShortableYes LT Debt/Eq0.69 EarningsFeb 27 BMO Payout- Avg Volume1.04M Price65.50
Recom2.30 SMA20-1.68% SMA50-17.72% SMA200-16.80% Volume668,365 Change-4.14%
Mar-05-20Upgrade Wells Fargo Equal Weight → Overweight $85 → $90
Jan-02-20Downgrade Evercore ISI Outperform → In-line $84 → $90
Jul-29-19Upgrade SunTrust Hold → Buy
Jul-26-19Downgrade Wedbush Outperform → Neutral $57 → $80
Jul-26-19Downgrade JP Morgan Overweight → Neutral $61 → $79
Mar-20-19Initiated SunTrust Hold
Nov-02-18Downgrade Wells Fargo Outperform → Market Perform
Jul-16-18Initiated Evercore ISI Outperform $46
Apr-18-18Reiterated Mizuho Buy $28 → $32
Feb-23-18Reiterated Mizuho Buy $25 → $28
May-24-17Upgrade Wells Fargo Market Perform → Outperform
Jul-29-16Reiterated Wedbush Outperform $30 → $20
Jan-19-16Initiated Barclays Underweight $16
Dec-02-15Initiated Deutsche Bank Hold $28
Oct-27-15Initiated Wedbush Outperform
Oct-27-15Initiated JP Morgan Overweight
Oct-27-15Initiated JMP Securities Mkt Outperform $43
Mar-23-20 12:24AM  Hedge Funds Started Selling NovoCure Limited (NVCR) Before The Coronavirus Insider Monkey
Mar-20-20 09:16AM  German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany Business Wire -6.68%
Mar-19-20 07:30AM  Novocure Announces Optune Lua as the Brand Name for the NovoTTF-100L System Business Wire +9.50%
Mar-12-20 07:30AM  Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy Business Wire
Mar-10-20 03:18AM  Edited Transcript of NVCR earnings conference call or presentation 27-Feb-20 1:00pm GMT Thomson Reuters StreetEvents
Feb-27-20 07:30AM  NovoCure (NVCR) Q4 Earnings and Revenues Beat Estimates Zacks
06:00AM  Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update Business Wire
Feb-20-20 12:31PM  NovoCure (NVCR) Earnings Expected to Grow: Should You Buy? Zacks
Feb-11-20 08:54AM  Is NovoCure Limited's (NASDAQ:NVCR) CEO Paid Enough Relative To Peers? Simply Wall St.
Feb-05-20 09:15AM  NASDAQ Reaches New Closing High as Rebound Continues Zacks
Feb-04-20 02:56PM  Expand Your Portfolio with this First Profit Stock Screener Zacks
Jan-29-20 09:15AM  Relief Rally Snaps the Dow's 5-Day Losing Skid Zacks
Jan-23-20 07:24AM  The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment Benzinga
Jan-21-20 04:35PM  Why This Leading Medtech Stock Nabbed A Second Breakout In A Week Investor's Business Daily
07:40AM  Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Business Wire
Jan-17-20 10:17AM  Stock Market Sets More Record Highs; Home Depot, Pinterest, Tesla, Twitter Key Movers Investor's Business Daily
Jan-16-20 04:45PM  IBD Stock Of The Day Breaks Out On Bullish Preliminary Sales Report Investor's Business Daily +11.84%
Jan-13-20 06:00AM  Novocure Announces Fourth Quarter and Full Year 2019 Preliminary Net Revenues and Provides Company Update Business Wire
Jan-09-20 07:30AM  Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer GlobeNewswire
Jan-03-20 08:40AM  Small-cap woes highlight stock markets dependency on mega-cap names MarketWatch
Dec-26-19 07:30AM  Novocure to Participate in the 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-08-19 07:11PM  Heres What Hedge Funds Think About NovoCure Limited (NVCR) Insider Monkey
Dec-04-19 04:05PM  SI-BONE Names Jeryl (Jeri) Hilleman to Board of Directors GlobeNewswire
09:55AM  Raise Stops on NovoCure TheStreet.com
Dec-02-19 07:30AM  Novocure and the AACR Announce 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program Business Wire
05:00AM  Novocure- A New Way to Target Tumors MoneyShow
Nov-26-19 07:30AM  Novocure to Participate in the Evercore ISI 2019 HealthCONx Conference TEST Business Wire Releases
07:30AM  Novocure to Participate in the Evercore ISI 2019 HealthCONx Conference Business Wire
Nov-20-19 07:30AM  Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology Business Wire
Nov-04-19 09:35AM  Edited Transcript of NVCR earnings conference call or presentation 31-Oct-19 12:00pm GMT Thomson Reuters StreetEvents
Nov-01-19 11:10AM  NovoCure Looks Ready to Resume Its Strong Uptrend After a Correction TheStreet.com +5.19%
Oct-31-19 07:35AM  NovoCure (NVCR) Q3 Earnings and Revenues Beat Estimates Zacks
06:00AM  Novocure Reports Third Quarter 2019 Financial Results and Provides Company Update Business Wire
06:00AM  Novocure Ltd. to Host Earnings Call ACCESSWIRE
Oct-27-19 10:08AM  3 Monster Growth Stocks to Hold Through 2020 TipRanks
Oct-24-19 10:32AM  Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-18-19 07:35AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
Oct-16-19 10:31AM  Results from STELLAR Trial of Tumor Treating Fields with Chemotherapy in Malignant Pleural Mesothelioma Published in The Lancet Oncology Business Wire
Oct-14-19 06:13PM  Did Hedge Funds Drop The Ball On NovoCure Limited (NVCR) ? Insider Monkey
01:31PM  How Many NovoCure Limited (NASDAQ:NVCR) Shares Have Insiders Sold, In The Last Year? Simply Wall St.
Oct-01-19 07:30AM  Novocure to Report Third Quarter 2019 Financial Results Business Wire
Sep-13-19 06:59PM  Novocure (NVCR) CFO Wilhelmus Cm Groenhuysen Sold $3.9 million of Shares GuruFocus.com
Sep-11-19 07:15PM  Novocure (NVCR) CFO Wilhelmus Cm Groenhuysen Sold $3.9 million of Shares GuruFocus.com
Sep-09-19 11:34AM  10 Stocks to Sell in Market-Cursed September InvestorPlace -8.23%
09:25AM  Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting Business Wire
Sep-04-19 09:44AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
Aug-30-19 06:54PM  Small-Cap Stocks Show Stealth Buying Pattern Investopedia
Aug-29-19 08:50AM  Is NovoCure (NASDAQ:NVCR) Weighed On By Its Debt Load? Simply Wall St.
Aug-27-19 11:37AM  Jim Cramer Gives His Opinion On Novocure, Morgan Stanley And More Benzinga
Aug-14-19 05:38AM  Novocure's Charts Are as Bullish As They Get, So Here's My Strategy TheStreet.com
Aug-13-19 07:01AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
Aug-12-19 07:30AM  China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China GlobeNewswire
07:30AM  China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China Business Wire
Aug-07-19 11:17AM  Jim Cramer Weighs In On Funko, Citigroup And More Benzinga
10:26AM  NovoCure Looks Due for a Technical Correction TheStreet.com
Aug-06-19 09:01AM  Novocure to Participate in Three Upcoming Investor Conferences Business Wire
Aug-04-19 07:00PM  Why NovoCure Stock Soared 32% in July Motley Fool
Jul-31-19 01:13AM  NovoCure Limited (NVCR) Q2 2019 Earnings Call Transcript Motley Fool
Jul-30-19 12:32AM  Edited Transcript of NVCR earnings conference call or presentation 25-Jul-19 12:00pm GMT Thomson Reuters StreetEvents
Jul-26-19 08:57AM  NovoCure Limited (NVCR) Shares March Higher, Can It Continue? Zacks
Jul-25-19 02:52PM  Why NovoCure Stock Is Surging Today Motley Fool +8.58%
01:59PM  NovoCure Nears Profitability as Revenue Continues to Soar Motley Fool
07:30AM  NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:00AM  Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update Business Wire
Jul-24-19 07:54AM  Are Investors Undervaluing NovoCure Limited (NASDAQ:NVCR) By 43%? Simply Wall St.
Jul-22-19 10:11AM  Can NovoCure's (NVCR) Steady Optune Business Aid Q2 Earnings? Zacks
07:30AM  Novocure Announces 10 Oral Presentations and a Special Session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology Conference Business Wire
Jul-18-19 07:11PM  CMS Establishes 2019 Monthly Fee Schedule Amount for Optune® Business Wire
10:33AM  NovoCure (NVCR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
06:57AM  Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma Business Wire
Jul-05-19 03:32PM  Novocure Stock Gave Quick Swing Trading Profit Investor's Business Daily
Jul-03-19 08:21AM  Why NovoCure Stock Jumped 19% in June Motley Fool
Jul-02-19 07:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $11.7 million of Shares GuruFocus.com
07:30AM  Novocure to Report Second Quarter 2019 Financial Results Business Wire
Jun-29-19 06:00AM  3 Cancer-Treatment Stocks to Buy Motley Fool
Jun-28-19 09:00AM  NovoCure (NVCR) Jumps: Stock Rises 7.1% Zacks
Jun-26-19 07:30AM  German Institute for Quality and Efficiency in Healthcare Publishes Rapid Report Noting Optunes Survival Benefit for Patients with Newly Diagnosed Glioblastoma Business Wire
Jun-24-19 08:22AM  What does NovoCure Limited's (NASDAQ:NVCR) Balance Sheet Tell Us About Its Future? Simply Wall St.
Jun-19-19 07:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $11.3 million of Shares GuruFocus.com
Jun-18-19 10:44AM  Novocure Could Climb Even Further; Here's Where to Buy TheStreet.com
Jun-14-19 09:08AM  Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR) Insider Monkey
Jun-12-19 04:39PM  Why NovoCure's Regulatory News Is a Huge Win for Investors Motley Fool
03:13PM  Is NovoCure Limited's (NASDAQ:NVCR) CEO Overpaid Relative To Its Peers? Simply Wall St.
Jun-07-19 08:34AM  You Need This IPO On Your Radar Motley Fool
Jun-06-19 07:50AM  Why NovoCure Stock Jumped 20.5% in May Motley Fool
Jun-03-19 07:45AM  3 Fast-Growing Healthcare Stocks to Buy If the Market Crashes Motley Fool
May-24-19 07:44AM  The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice Benzinga +7.30%
07:30AM  Novocure to Participate in the Jefferies 2019 Global Healthcare Conference Business Wire
May-23-19 04:05PM  FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma Business Wire
May-13-19 03:00AM  Insulet and Novocure Are Going Gangbusters Motley Fool
May-10-19 06:30AM  Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma Business Wire
May-08-19 04:10PM  Edited Transcript of NVCR earnings conference call or presentation 2-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-07-19 10:38AM  5 Key Takeaways From NovoCure's Big First-Quarter Motley Fool
May-03-19 12:48AM  NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript Motley Fool +9.62%
May-02-19 12:02PM  NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript Motley Fool
08:16AM  The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data Benzinga
07:30AM  NovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:18AM  NovoCure: 1Q Earnings Snapshot Associated Press
06:00AM  Novocure Reports First Quarter 2019 Financial Results and Provides Company Update Business Wire
Apr-30-19 02:20PM  The NovoCure (NASDAQ:NVCR) Share Price Is Up 275% And Shareholders Are Boasting About It Simply Wall St.
Markets a wearable electric field device for treating glioblastoma brain cancer.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shah PriteshChief Commercial OfficerMar 06Option Exercise7.4817,500130,900103,938Mar 10 04:20 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerMar 06Sale69.533,123217,155140,386Mar 10 04:13 PM
Longsworth Todd ChristopherGeneral CounselMar 06Sale69.532,499173,76586,753Mar 10 04:15 PM
DOYLE WILLIAM FExecutive ChairmanMar 06Sale69.534,320300,387510,511Mar 10 04:18 PM
Shah PriteshChief Commercial OfficerMar 06Sale66.766,151410,62286,438Mar 10 04:20 PM
Ambrogi Michael J.Chief Operating OfficerMar 06Sale69.532,274158,120220,867Mar 10 04:22 PM
Shah PriteshChief Commercial OfficerMar 02Sale72.971,485108,36067,721Mar 05 04:47 PM
Shah PriteshChief Commercial OfficerFeb 28Sale72.221,601115,61669,206Mar 02 05:22 PM
Longsworth Todd ChristopherGeneral CounselFeb 28Sale72.222,643190,86470,032Mar 02 05:11 PM
DOYLE WILLIAM FExecutive ChairmanFeb 28Sale72.223,893281,133514,831Mar 02 05:13 PM
Ambrogi Michael J.Chief Operating OfficerFeb 28Sale72.222,673193,031208,726Mar 02 05:17 PM
Ambrogi Michael J.Chief Operating OfficerFeb 27Option Exercise79.456,173490,445211,399Mar 02 05:17 PM
Danziger AsafChief Executive OfficerFeb 27Option Exercise79.459,259735,628197,348Mar 02 05:15 PM
DOYLE WILLIAM FExecutive ChairmanFeb 27Option Exercise79.459,259735,628518,724Mar 02 05:13 PM
Longsworth Todd ChristopherGeneral CounselFeb 27Option Exercise79.455,556441,42472,675Mar 02 05:11 PM
Shah PriteshChief Commercial OfficerFeb 27Option Exercise79.453,086245,18370,807Mar 02 05:22 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 27Option Exercise0.007,7160119,484Mar 02 05:18 PM
Shah PriteshChief Commercial OfficerFeb 26Sale79.397,932629,72567,721Feb 28 04:41 PM
Ambrogi Michael J.Chief Operating OfficerFeb 25Sale81.1611,647945,224205,226Feb 26 05:10 PM
Longsworth Todd ChristopherGeneral CounselFeb 25Sale81.168,482688,36567,119Feb 26 05:14 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 25Sale81.1618,9081,534,498111,768Feb 26 05:17 PM
Shah PriteshChief Commercial OfficerFeb 25Sale81.165,067411,21775,653Feb 28 04:41 PM
Danziger AsafChief Executive OfficerFeb 24Option Exercise88.2653,3334,707,171188,089Feb 26 05:19 PM
Shah PriteshChief Commercial OfficerFeb 24Option Exercise88.2612,9991,147,29280,720Feb 26 05:18 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerFeb 24Option Exercise88.2643,3333,824,571130,676Feb 26 05:17 PM
Longsworth Todd ChristopherGeneral CounselFeb 24Option Exercise88.2621,6661,912,24175,601Feb 26 05:14 PM
Ambrogi Michael J.Chief Operating OfficerFeb 24Option Exercise88.2631,1992,753,624216,873Feb 26 05:10 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerJan 22Option Exercise7.032,91520,49288,858Jan 24 07:11 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerJan 22Sale98.142,915286,08487,343Jan 24 07:11 PM
DOYLE WILLIAM FExecutive ChairmanJan 17Sale95.00133,77712,708,815509,465Jan 22 04:19 PM
PHILLIPS CHARLES G IIIDirectorDec 02Sale88.116,145541,4483,359Dec 04 04:23 PM
LEUNG GABRIELDirectorNov 25Option Exercise7.0320,000140,60089,504Nov 26 04:23 PM
Danziger AsafChief Executive OfficerNov 25Option Exercise22.00103,0002,266,000237,601Nov 26 04:28 PM
LEUNG GABRIELDirectorNov 25Sale95.0020,0001,900,00069,504Nov 26 04:23 PM
Danziger AsafChief Executive OfficerNov 25Sale95.00103,0009,785,000134,601Nov 26 04:28 PM
DOYLE WILLIAM FExecutive ChairmanNov 25Sale96.0416,2231,558,057643,242Nov 26 04:29 PM
LEUNG GABRIELDirectorNov 20Option Exercise7.0320,000140,60089,504Nov 22 04:27 PM
DOYLE WILLIAM FExecutive ChairmanNov 20Sale90.36150,00013,553,723659,465Nov 22 04:22 PM
LEUNG GABRIELDirectorNov 20Sale90.0020,0001,800,00069,504Nov 22 04:27 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 18Option Exercise3.445,83220,06293,011Nov 19 04:22 PM
LEUNG GABRIELDirectorNov 18Option Exercise7.0310,00070,30079,504Nov 19 04:24 PM
LEUNG GABRIELDirectorNov 18Sale85.0010,000850,00069,504Nov 19 04:24 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 18Sale85.995,832501,47087,179Nov 19 04:22 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 15Option Exercise3.4420,00068,800107,179Nov 19 04:22 PM
LEUNG GABRIELDirectorNov 15Option Exercise5.3310,00053,27374,761Nov 19 04:24 PM
LEUNG GABRIELDirectorNov 15Sale83.2410,000832,35469,504Nov 19 04:24 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 15Sale83.2520,0001,665,09387,179Nov 19 04:22 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 14Option Exercise3.7527,576103,503107,179Nov 15 04:25 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 14Sale81.8727,5762,257,68987,179Nov 15 04:25 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 13Option Exercise4.3440,000173,500107,179Nov 15 04:25 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 13Sale80.8740,0003,234,61787,179Nov 15 04:25 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 12Option Exercise4.3440,000173,500107,179Nov 13 04:30 PM
DOYLE WILLIAM FExecutive ChairmanNov 12Sale81.6813,2181,079,616809,465Nov 13 04:31 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 12Sale80.1740,0003,206,81087,179Nov 13 04:30 PM
LEUNG GABRIELDirectorNov 11Option Exercise3.445,00017,20074,504Nov 13 04:33 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 11Option Exercise4.238,60036,40591,979Nov 13 04:30 PM
DOYLE WILLIAM FExecutive ChairmanNov 11Sale80.1129,7822,385,776822,683Nov 13 04:31 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 11Sale80.138,600689,11587,179Nov 13 04:30 PM
LEUNG GABRIELDirectorNov 11Sale79.575,000397,85069,504Nov 13 04:33 PM
Ambrogi Michael J.Chief Operating OfficerNov 04Option Exercise20.6980,8191,672,467222,631Nov 06 04:27 PM
Ambrogi Michael J.Chief Operating OfficerNov 04Sale79.0080,8196,384,701185,674Nov 06 04:27 PM
Shah PriteshChief Commercial OfficerOct 24Option Exercise7.484,58034,25867,721Oct 28 04:28 PM
LEUNG GABRIELDirectorOct 10Option Exercise3.445,00017,20074,504Oct 15 04:12 PM
LEUNG GABRIELDirectorOct 10Sale72.285,000361,40069,504Oct 15 04:12 PM
GROENHUYSEN WILHELMUS CMCFOSep 24Option Exercise4.327,99234,53291,210Sep 26 07:52 PM
GROENHUYSEN WILHELMUS CMCFOSep 24Sale80.637,992644,39887,179Sep 26 07:52 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 16Option Exercise3.4425,00086,000112,179Sep 17 04:37 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 16Sale78.9325,0001,973,33487,179Sep 17 04:37 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 13Option Exercise3.4425,00086,000112,179Sep 17 04:37 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 13Sale79.8225,0001,995,54887,179Sep 17 04:37 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 12Option Exercise3.4425,00086,000112,179Sep 13 04:16 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 12Sale79.5725,0001,989,27887,179Sep 13 04:16 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 11Option Exercise3.4425,00086,000112,179Sep 13 04:16 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 11Sale77.9825,0001,949,56487,179Sep 13 04:16 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 10Option Exercise3.4425,00086,000112,179Sep 11 04:11 PM
LEUNG GABRIELDirectorSep 10Option Exercise3.445,00017,20074,504Sep 12 04:04 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 10Sale75.5525,0001,888,63587,179Sep 11 04:11 PM
LEUNG GABRIELDirectorSep 10Sale76.635,000383,15069,504Sep 12 04:04 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 09Option Exercise3.4425,00086,000112,179Sep 11 04:11 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 09Sale80.8325,0002,020,74687,179Sep 11 04:11 PM
Longsworth Todd ChristopherGeneral CounselSep 03Option Exercise9.64158,4401,528,047113,420Sep 05 04:09 PM
Longsworth Todd ChristopherGeneral CounselSep 03Sale87.87158,44013,922,58953,900Sep 05 04:09 PM
PHILLIPS CHARLES G IIIDirectorAug 30Option Exercise6.7222,000147,84031,504Sep 03 04:22 PM
PHILLIPS CHARLES G IIIDirectorAug 30Sale91.1422,0002,005,1189,504Sep 03 04:22 PM
Danziger AsafChief Executive OfficerAug 29Sale91.13124,18111,316,198134,601Sep 03 04:24 PM
VERNON W ANTHONYDirectorAug 29Sale91.03100,0009,103,100158,589Sep 03 04:20 PM
LEUNG GABRIELDirectorAug 12Option Exercise3.445,00017,20074,504Aug 14 04:18 PM
LEUNG GABRIELDirectorAug 12Sale86.455,000432,25069,504Aug 14 04:18 PM
Shah PriteshChief Commercial OfficerAug 02Sale85.231,813154,52276,976Aug 06 04:43 PM
Shah PriteshChief Commercial OfficerAug 01Sale83.201,905158,50278,789Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 31Option Exercise54.758,833483,61982,091Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 31Sale82.925,115424,13676,976Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 26Option Exercise19.2512,500240,62589,476Jul 30 03:57 PM
Shah PriteshChief Commercial OfficerJul 26Sale77.9412,500974,20876,976Jul 30 03:57 PM
Shah PriteshChief Commercial OfficerJul 18Option Exercise27.607,500207,00084,476Jul 22 10:47 AM
Shah PriteshChief Commercial OfficerJul 18Sale70.007,500525,00076,976Jul 22 10:47 AM
LEUNG GABRIELDirectorJul 10Option Exercise3.445,00017,20074,504Jul 12 04:04 PM
LEUNG GABRIELDirectorJul 10Sale64.835,000324,15569,504Jul 12 04:04 PM
Danziger AsafChief Executive OfficerJun 28Option Exercise7.15187,5001,340,625445,811Jul 02 04:12 PM
Danziger AsafChief Executive OfficerJun 28Sale62.15187,50011,653,125258,311Jul 02 04:12 PM
open in yahoo | open in reuters | open in google